![Jeffrey L. Cleland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey L. Cleland
Fondateur chez
Orpheris, Inc.
Profil
Jeffrey L.
Cleland was the founder of Targesome, Inc., founded in 2002, serving as Vice President-Research & Development from 2002 to 2003.
Dr. Cleland was the founder of Ashvattha Therapeutics Inc, founded in 2016, serving as Chairman from 2025 to 2026.
Dr. Cleland is the founder of Versartis, Inc., founded in 2008, serving as President, Chief Executive Officer & Director from 2014 to 2015.
Dr. Cleland is the founder of Diartis Pharmaceuticals, Inc., founded in 2010, serving as Chief Executive Officer in 2011.
Dr. Cleland is the founder of Orpheris, Inc., founded in 2015, serving as Executive Chairman since 2015.
Current jobs include Director at Elixirgen Therapeutics, Inc. since 2022, Director at ImmunSYS, Inc., Director at Syncromune, Inc., and Member of the American Chemical Society, the American Institute of Chemical Engineers, and The Controlled Release Society.
Former jobs include President, Chief Executive Officer & Director at Graybug Vision, Inc. from 2015 to 2018; President & Chief Executive Officer at Ilypsa, Inc.; Independent Director at Exicure, Inc. from 2019 to 2023; Director at Exicure Operating Co.; Senior Scientist at Genentech, Inc.; Vice President-Therapeutic Development at BaroFold, Inc. from 2007 to 2009; Vice President-Technical Operations at Novacea, Inc.; and Member of the American Association for the Advancement of Science.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of California, Davis.
Postes actifs de Jeffrey L. Cleland
| Sociétés | Poste | Début |
|---|---|---|
The Controlled Release Society
 The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services Provides fundamental delivery research, development, regulatory science and clinical translation | Corporate Officer/Principal | - |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Corporate Officer/Principal | - |
American Institute of Chemical Engineers
 American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization for chemical engineers | Corporate Officer/Principal | - |
Orpheris, Inc.
 Orpheris, Inc. BiotechnologyHealth Technology Develop dendrimer technology to address unmet medical needs in orphan diseases | Fondateur | 01/01/2015 |
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Directeur/Membre du Conseil | - |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops intratumoral immunotherapy platform for treating metastatic solid tumors | Directeur/Membre du Conseil | - |
Elixirgen Therapeutics, Inc.
 Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells stem cell therapies for genetic diseases | Directeur/Membre du Conseil | 21/12/2022 |
Anciens postes connus de Jeffrey L. Cleland
| Sociétés | Poste | Fin |
|---|---|---|
Ashvattha Therapeutics Inc
 Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Général | 14/10/2025 |
| EXICURE, INC. | Directeur/Membre du Conseil | 10/02/2023 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Jeffrey L. Cleland
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes protein therapeutics | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
American Association for the Advancement of Science
 American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services Provides science related journal, program, and education services | Commercial Services |
American Institute of Chemical Engineers
American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization for chemical engineers | Commercial Services |
The Controlled Release Society
The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services Provides fundamental delivery research, development, regulatory science and clinical translation | Commercial Services |
Targesome, Inc.
 Targesome, Inc. Medical/Nursing ServicesHealth Services Develops antibody targeting technologies for treatment of cancer | Health Services |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Diartis Pharmaceuticals, Inc.
 Diartis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic proteins for the treatment of metabolic disorders | Health Technology |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
Ashvattha Therapeutics Inc
Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Orpheris, Inc.
Orpheris, Inc. BiotechnologyHealth Technology Develop dendrimer technology to address unmet medical needs in orphan diseases | Health Technology |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells stem cell therapies for genetic diseases | Health Technology |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Health Technology |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops intratumoral immunotherapy platform for treating metastatic solid tumors | Health Technology |
